We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$3.25B
AUM Growth
+$336M
Cap. Flow
+$192M
Cap. Flow %
5.9%
Top 10 Hldgs %
66.02%
Holding
47
New
8
Increased
9
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$127M
2
WBA
Walgreens Boots Alliance
WBA
+$53.2M
3
CNMD icon
CONMED
CNMD
+$31.4M
4
UHS icon
Universal Health Services
UHS
+$31.1M
5
GSK icon
GSK
GSK
+$29.7M

Top Sells

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$95.9M
2
SNY icon
Sanofi
SNY
+$73M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$64.9M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$64.3M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$39.6M

Sector Composition

Rank Sector Weight
1 Healthcare 88.91%
2 Consumer Staples 0.6%
3 Consumer Discretionary 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$450B
$321M 9.87%
+1,000,000
New +$295M
SNY icon
2
Sanofi
SNY
$103B
$299M 9.2%
5,500,000
-1,500,000
-21% -$73M
UHS icon
3
Universal Health Services
UHS
$9.88B
$245M 7.52%
1,925,000
+225,000
+13% +$31.1M
THC icon
4
Tenet Healthcare
THC
$21.8B
$229M 7.04%
3,850,000
-150,000
-4% -$8.34M
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
$225M 6.91%
6,500,000
+1,500,000
+30% +$53.2M
VTRS icon
6
Viatris
VTRS
$20.7B
$216M 6.66%
22,500,000
+2,500,000
+13% +$27.7M
GSK icon
7
GSK
GSK
$104B
$164M 5.03%
4,600,000
+850,000
+23% +$29.7M
MYGN icon
8
Myriad Genetics
MYGN
$507M
$163M 5%
7,000,000
– –
ZBH icon
9
Zimmer Biomet
ZBH
$18.4B
$162M 4.97%
1,250,000
– –
SEM
10
DELISTED
Select Medical
SEM
$124M 3.82%
8,908,800
– –
BAX icon
11
Baxter International
BAX
$13.8B
$122M 3.74%
+3,000,000
New +$127M
PTCT icon
12
PTC Therapeutics
PTCT
$6.26B
$121M 3.72%
2,500,000
-250,000
-9% -$11.4M
SRPT icon
13
Sarepta Therapeutics
SRPT
$1.64B
$103M 3.18%
750,000
-500,000
-40% -$64.9M
PRGO icon
14
Perrigo
PRGO
$1.43B
$89.7M 2.76%
2,500,000
– –
XRAY icon
15
Dentsply Sirona
XRAY
$2.75B
$69.3M 2.13%
1,765,000
– –
IONS icon
16
Ionis Pharmaceuticals
IONS
$8.81B
$68.8M 2.12%
1,925,000
– –
BKD icon
17
Brookdale Senior Living
BKD
$3.49B
$53.1M 1.63%
18,000,000
– –
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$52.1M 1.6%
1,400,000
– –
QTRX icon
19
Quanterix
QTRX
$166M
$38.6M 1.19%
3,425,000
– –
CNMD icon
20
CONMED
CNMD
$1.41B
$33.8M 1.04%
+325,000
New +$31.4M
EXEL icon
21
Exelixis
EXEL
$14.1B
$30.1M 0.93%
1,550,000
+200,000
+15% +$3.48M
TEVA icon
22
Teva Pharmaceuticals
TEVA
$41.2B
$26.6M 0.82%
3,000,000
-4,000,000
-57% -$39.6M
OSUR icon
23
OraSure Technologies
OSUR
$273M
$25.7M 0.79%
4,250,000
– –
CNC icon
24
Centene
CNC
$30.1B
$25.3M 0.78%
+400,000
New +$28.4M
COLL icon
25
Collegium Pharmaceutical
COLL
$1.17B
$25.2M 0.77%
1,050,000
– –
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Camber Capital Management held 47 positions worth $3.25B, up 12% from $2.92B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Camber Capital Management deployed $192M of net new capital in Q1 2023, opening 8 new positions and adding to 9 existing holdings. Its largest new stake was Baxter International: 3,000,000 shares worth $122M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 97% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Align Technology, an estimated $95.9M trimmed.

  • Camber Capital Management's largest Q1 2023 buy was Baxter International: 3,000,000 shares worth $122M.
  • Camber Capital Management added most to Walgreens Boots Alliance in Q1 2023, an estimated $53.2M increase.
  • Camber Capital Management's biggest Q1 2023 reduction was Align Technology, cutting an estimated $95.9M.
  • Camber Capital Management fully exited Seagen Inc. Common Stock in Q1 2023, selling an estimated $64.3M.
  • Camber Capital Management's ten largest holdings make up 66% of its $3.25B portfolio in Q1 2023.
  • Camber Capital Management opened 8 new positions and closed 6 in Q1 2023.
  • Camber Capital Management's portfolio value rose 12% quarter-over-quarter to $3.25B.

Based on Camber Capital Management's 13F filing for Q1 2023, filed 15 May 2023.